Related Experiment Video
Updated: May 14, 2026
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin
Hanne Lund1, Ann Helene Snilsberg, Trine Grønhaug Halvorsen
1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo, Oslo, Norway.
Background:
The performance of a method for MS determination of human chorionic gonadotropin (hCG) was compared with a reference method currently used in World Anti-Doping Agency accredited doping laboratories - the DELFIA(®) immunoassay.
Results:
A strong correlation was demonstrated for the serum samples. However, for the urine samples, DELFIA reported significantly lower quantitative hCG measurements than the MS method. This was explained by the relatively unstable content of intact hCG-heterodimer in urine during storage compared with in serum. Discrepancies observed for the urine analyses might be related to the molecular dissociation of intact hCG-heterodimer into free subunits during storage, and the direct effect this has on the intact hCG measurements provided by DELFIA. The MS method quantified both intact hCG and free hCG β-subunit simultaneously, and was thus less susceptible to this problem. However, both methods detected illicit levels of serum hCG an equally long time after administration.
Conclusion:
The presented work advocates the implementation of this MS method as a confirmatory method for hCG determination in doping laboratories.
More Related Videos
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
10:10Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
Published on: November 13, 2021